Hasil Pencarian  ::  Simpan CSV :: Kembali

"Pendahuluan: Pasien yang dirawat di ICU berisiko tinggi terserang kandidiasis invasif. Pemberian antijamur empirik dini dapat memperbaiki kondisi klinis pasien dan menurunkan angka kematian. Candida Score dari Leon mempunyai sensitifitas dan spesifisitas yang baik untuk menggolongkan pasien ICU yang memang benar membutuhkan terapi empirik antijamur. Penelitian ini menganalisis kesesuaian kriteria Candida Score dan hasil kultur darah dengan pemberian antijamur pada pasien sepsis di ICU RSCM.Metodologi: Studi potong lintang dilakukan pada pasien sepsis di ICU RSCM pada Maret 2015-Oktober 2015. Dilakukan kultur pada spesimen darah, urin, dan sekret saluran nafas, selanjutnya dibiakkan. Karakteristik pasien dan riwayat klinisnya dicatat. Candida Score dihitung pada setiap pasien kemudian diuji asosiasinya dengan terapi yang didapatkan.Hasil: Dari 100 pasien 57 pasien mendapatkan antijamur. Proporsi pasien yang mendapat antijamur yaitu 50 , 17 , 57 , 83 , dan 100 pada kelompok pasien dengan Candida score 0-4 berturut-turut. Dalam penelitian ini tidak kami dapatkan pasien dengan Candida score=5. Hasil kultur darah positif Candida didapatkan pada 4 orang pasien dengan angka kematian sebesar 100 . Tiga pasien kandidemia dengan Candida score >3 mendapatkan antijamur setelah hasil kultur darah positif Candida.Kesimpulan: Terdapat asosiasi bermakna antara kriteria Candida score dengan pemberian antijamur pada pasien sepsis di ICU RSCM p3 tidak mendapatkan terapi empirik.

---

Introduction Prompt empirical antifungal therapy is essential for controling invasive candidiasis and has been shown to reduce mortality. Candida Score, established by Leon, has a good sensitivity and specivicity to distinguish critically ill patients whose invasive candidiasis is highly probable. This study analyzed the conformity between candida score criteria and blood culture results with the antifungal administration in patients with sepsis at the ICU of Dr. Cipto Mangunkusumo General Hospital RSCMMethods A cross sectional study was conducted from March October 2015 at the ICU of RSCM. Critically ill patients who exhibited sepsis were included in this study. The urine, blood, and respiratory secrete were collected and were cultured in the microbiology laboratory. Each patient rsquo s characteristics and medical history were also recorded. The candida score was calculated and then tested for their association with treatment obtained.Results Of the 100 patients, 57 patients received antifungal therapy, with the proportion of 50 , 17 , 57 , 83 , and 100 in the patients group broken by the Candida Score of 0 to 4 respectively. There rsquo s no patient with Candida Score of 5. Candida positive blood culture results candidaemia were observed in 4 patients, with a mortality rate of 100 . Three of which had the score of 3 but received antifungal therapy after the positive blood culture results were obtained.Conclusion There is a significant association between Candida Score criteria with antifungal administration in septic patients in the ICU of RSCM p 3 did not get empiric antifungal therapy. "

"ABSTRAK Latar belakangKematian akibat sepsis dan syok septik pada pasien rawatan Intensive Care Unit (ICU) yaitu 20-30%. Pemberian antibiotik empirik yang tepat merupakan salah satu langkah awal yang sangat penting. Amikasin merupakan salah satu antibiotik terpilih untuk tata laksana sepsis di ICU RSUPN dr. Cipto Mangunkusumo (RSCM). Saat ini belum pernah dilakukan penelitian mengenai ketercapaian kadar terapi amikasin dengan menggunakan dosis standar amikasin pada pasien sepsis dewasa di ICU RSCM, sehingga studi ini menjadi penelitian pertama di Indonesia.Penelitian ini bertujuan untuk mengetahui ketercapaian kadar amikasin optimal pada pasien ICU RSCM.MetodeData dikumpulkan secara potong lintang melalui observasi terhadap hasil pemeriksaan kadar plasma amikasin, pengukuran minimum inhibitory concentration (MIC) dan perhitungan rasio Cmax/MIC pada pasien sepsis di ICU RSCM periode Mei-September tahun 2015.Hasil penelitianProporsi pasien sepsis dengan kadar amikasin optimal ialah sebesar 57% (4/7). Kadar puncak amikasin yang dapat dicapai dengan dosis 1000 mg sekali sehari tanpa menghiraukan berat badan ialah median 86,4 (43,5-238) µg/mL. Pada penelitian ini ditemukan 87% pasien dengan kadar puncak amikasin di atas 64 µg/mL, meskipun amikasin 1000 mg tersebut lebih rendah dari dosis yang dianjurkan untuk sepsis (25 mg/kgBB). Sebagian besar (78,3 %) subyek pada kenyataannya menerima dosis 15-25 mg/kgBB, dengan pemberian 1000 mg amikasin tanpa memperhatikan berat badan. Bakteri yang banyak ditemukan dari hasil kultur pasien sepsis di ICU RSCM, yaitu K. pneumoniae, A. baumanii, P. aeruginosa dan E. coli. Rentang nilai MIC untuk patogen tersebut berturut-turut yaitu 0,75 - >256 µg/mL, 0,75 - >256 µg/mL, 1,5 - >256 µg/mL dan 0,75 - 16) µg/mL. Sebanyak 84% isolat K. pneumoniae masih sensitif terhadap amikasin, diikuti oleh 63% untuk A. baumanii, 47% P. aeruginosa dan 100% untuk E. coli.KesimpulanOptimalitas amikasin terhadap bakteri Gram negatif penyebab sepsis bergantung kadar puncak dan MIC bakteri. Kadar puncak plasma amikasin yang dicapai dengan dosis 1000 mg sekali sehari sangat bervariasi. Pemberian amikasin dengan dosis per kgBB dapat dipertimbangkan. Kepekaan beberapa bakteri Gram negatif terhadap amikasin mulai menurun dengan rentang MIC yang cukup lebar. Pengukuran ketercapaian kadar optimal dalam terapi definitif dapat dilakukan untuk meningkatkan keberhasilan terapi.ABSTRACT BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment.;BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment.;BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment."

"[Tingginya tingkat infeksi nosokomial di ICU menyebabkan penggunaan antibiotik ICU cenderung lebih tinggi dari ruang rawat yang lain. Penggunaan antibiotik ini sering kali tidak menunggu hasil uji kepekaan bakteri. Hal ini menyebabkan resistensi terhadap antibiotika semakin cepat terjadi. Tujuan penelitian ini adalah mengetahui jenis antibiotik yang banyak digunakan di ICU RSCM dan mengetahui jumlah penggunaan antibiotik berdasarkan perhitungan Defined Daily Dose (DDD) WHO di ICU RSCM periode Januari hingga Maret 2015. Penelitian ini merupakan penelitian deskriptif observasional dengan menggunakan rekam medis pasien. Dari 167 rekam medis yang diikutkan dalam penelitian ini, tiga antibiotik dengan frekuensi pemakaian terbanyak adalah meropenem (15.31%), seftriakson (14.43%), dan fosfomisin (11.57%). Hasil penilaian kuantitas penggunaan antibiotik berdasarkan metode DDD menunjukkan tiga antibiotik dengan DDD tertinggi adalah meropenem (433.51 DDD/1000 hari rawat), dilanjutkan dengan seftriakson (268.04 DDD/1000 hari rawat dan amikasin (180.41 DDD/1000 hari rawat). Hasil ini cukup tinggi jika dibandingkan dengan kuantitas penggunaan antibiotik rumah sakit lain, The high incidence nosocomial infection in Intensive Care Unit could increase the antibiotics administration. Furthermore, the administration of antibiotics often not based on the results of bacterial susceptibility test. This phenomenon cause the high level of bacterial resistance in ICU. The aim of this study was to determine the most frequent antibiotics used in ICU and to evaluate antibiotic consumption quantitatively using ACT/DDD method in ICU RSCM. This research is a descriptive-observasional study using medical record of the patient. From 167 medical records, three antibiotics with the highest frequency administration were meropenem (15.31%), ceftriaxone (14.43%), dan fosfomycin (11.57%). By using DDD method, three antibiotics with the highest DDD were meropenem (433.51 DDD/1000 bed days), ceftriaxone (268.04 DDD/1000 bed days), and amikacin (180.41 DDD/1000 bed days). This result is quite high when compared with antibiotic consumpsion in another hosp]"

"Kandidiasis orofaring yang disebabkan oleh C. albicans merupakan infeksi oportunistik yang paling sering terjadi pada pasien HIV/AIDS. Flukonazol telah digunakan secara luas untuk terapi kandidiasis. Beberapa penelitian saat ini telah melaporkan terjadinya resistensi spesies Candida terhadap flukonazol terutama pada pasien HIV/AIDS. Tujuan penelitian ini untuk melihat besarnya resistensi spesies Candida yang diisolasi dari pasien HIV/AIDS juga ingin diketahui categorical agreement antara metode otomatik Vitek2 dengan metode manual difusi cakram dalam menguji kepekaan spesies Candida terhadap antijamur. Penelitian potong lintang ini terdiri dari 137 isolat Candida yang didapatkan dari 86 subyek HIV/AIDS dengan Kandidiasis Orofaring di RSCM. Data karakteristik subyek dicatat dan dilakukan pengambilan swab orofaring. Identifikasi spesies dilakukan menggunakan media CHROMagar dan YST Vitek2. Uji kepekaan dilakukan memakai metode otomatik Vitek2 dan manual difusi cakram, kemudian dicari interpretasi error dan categorical agreement antara kedua metode. Didapatkan 8 spesies Candida yaitu C.albicans sebesar 77 (55,3%), C.glabrata 21(15,3%), C.tropicalis 19 (13,9%), C.krusei 9 (6,7%), C.parapsilosis 5 (3,6%), C.dubliniensis 4 (2,9%), C.famata 1 (0,76%), C.magnoliae 1 (0,76%). Angka resistensi C.albicans dengan Vitek2 terhadap FCA,VOR,AMB, dan FCT berturut turut adalah 0; 1,3%; dan 2,6%; dan 0, C.glabrata 9,5%; 9,5%; 5%; dan 0, C.krusei 100%; 0; 11,1%; dan 0, C.dubliniensis 0; 0; 25%; dan 0. Angka resistensi C.albicans dengan difusi cakram terhadap FCA,VOR,AMB berturut turut adalah 2,6%; 2,6%; 0, C.glabrata 52,4%; 23,8%; 23,8%, C.tropicalis 5,3%; 5,3%; 0, C.krusei 100%; 0; 11,1%, C.parapsilosis 0; 0; 2%. Categorical agreement uji resistensi antara metode otomatik Vitek2 dengan manual difusi cakram terhadap FCA, VOR, dan AMB berturut turut untuk C.albicans yaitu 90,9%; 92,2%; dan 98,7%, C.glabrata 19,05%; 71,4%; dan 80,95%, C.tropicalis 89,5%; 89,5%; dan 89,5%, C.krusei 100%; 88,9%; dan 55,6%, C.parapsilosis 100%; 100%; dan 80%, serta C.dubliniensis 75%; 100%; dan100%. Kami menyimpulkan C.albicans masih merupakan penyebab kandidiasis tersering, dan angka resistensi isolat Candida yang didapatkan dari subyek HIV/AIDS dengan kandidiasis orofaring di RSCM cukup rendah, kecuali C.krusei dan C.glabrata. Total categorical agreement untuk seluruh spesies Candida antara Vitek2 dengan difusi cakram cukup baik, kecuali untuk C.glabrata.

---

Oropharyngeal candidiasis caused by C. albicans is the most common opportunistic infection in patients with HIV / AIDS. Fluconazole has been used widely for the treatment of candidiasis. Recent studies have reported the occurrence of fluconazole resistance to Candida species, especially in HIV / AIDS patients. The purpose of this study is to determine frequency of resistance of Candida species isolated from patients with HIV / AIDS to antifungal drugs. Further, to explore the categorical agreement between Vitek2 automatic with manual disc diffusion method to determine the sensitivity of Candida species. This cross-sectional study conducted between October 2012 and March 2013 yield on 137 Candida isolates from 86 oropharyngeal candidiasis HIV/AIDS patients at RSCM. Data on baseline characteristic were recorded and isolation of Candidia species was obtained by performing oropharyngeal swab. Species identification using CHROMagar media and YST Vitek2 and sensitivity test by automatic Vitek2 methods and manual disc diffusion was performed. The error interpretation and categorical agreement between the two methods was then calculated We identified total of eight Candida species, 77 (55.3%) C.albicans and non albicans included C.glabrata 21 (15.3%) ; C.tropicalis 19 (13.9%) ; 9 (6.7%) C.krusei; 5 (3.6%) C.parapsilosis; 4 (2.9%) C.dubliniensis and 1 (0.76%) for each C.famata and C.magnoliae. Vitek2 resistance rates against C.albicans with fluconazole (FCA), voriconazole (VOR), amphoterisin B (AMB), and flucytosin (FCT) were 0; 1.3%; 2.6% and 0 respectively, C.glabrata 9.5%; 9.5%; 5% and 0, respectively. C.krusei 100%; 0; 11.1%, and 0 respectively. C.dubliniensis 0; 0; 25%, and 0. Using disc diffusion the resistance of FCA, VOR, AMB was 2.6%, 2.6%, 0 for C.albicans, C.glabrata 52.4%, 23.8%, 23.8%, C. tropicalis 5.3%, 5.3%, 0, C.krusei 100%; 0; 11.1%, C.parapsilosis 0; 0; 2%. Total categorical agreement for all Candida species against FCA, VOR and AMB, Vitek2 and disc diffusion method Vitek2 was C.albicans 90,9%; 92,2%; and 98,7%, C.glabrata 19,05%, 71,4%, and 80,95%, C.tropicalis 89,5%, 89,5%, and 89,5%, C.krusei 100%, 88,9%, and 55,6%, C.parapsilosis 100%, 100%, and 80% C.dubliniensis 75%, 100%, and 100% respectively. C.albicans still found as the most common caused of oropharyngeal candidiasis and remained sensitive to antifungal treatment. Among the non albicans species, susceptibilities of C.krusei and C.glabrata to antifungal treatment was poor. Sensitivity test using Vitek2 and disc diffusion methods resulted in excellent to"

"ABSTRAKLatar Belakang: Mortalitas pasien perforasi tukak peptik (PTP) masih stabil padaangka 20-50% dimana penyebab terbanyak adalah sepsis. Tantangan ini memicu paraahli bedah untuk meneliti faktor-faktor yang berhubungan dengan mortalitas danmorbiditas penyakit ini. Selain pembedahan untuk kontrol infeksi, antibiotikapreoperatif diketahui menurunkan angka mortalitas. Penelitian ini bertujuanmengetahui hubungan kesesuaian antibiotika empiris dengan hasil kultur sensitifitasantibiotika terhadap ketahanan hidup 30 hari pasien perforasi tukak peptik di RSUPNDr Cipto Mangunkusumo (RSCM) Jakarta. Metode: Studi kohort terhadap pasienPTP sejak Januari 2012 hingga Agustus 2015 di Departemen Bedah FKUI/RSCMJakarta, dimana PTP akibat keganasan dan trauma tembus dieksklusikan. Pola kumandan antibiotika pada pasien PTP disajikan sebagai studi pendahuluan. Hasil: dari 45pasien yang didapat, angka mortalitas pasien PTP di RSCM sebesar 31,1% danketahanan hidup sebesar 68,9%. Pola kuman pada pasien PTP adalah Escherichia colisebagai kuman Gram negatif terbanyak (35,85%) dan Streptococcus alfahemolyticsebagai kuman Gram positif terbanyak (15,09%). Antibiotika lini kedua yang sesuaiuntuk pasien PTP adalah Sulbactam/Ampicillin.Tidak terdapat hubungan antara skor Boey dan ketahan hidup, namun syok preoperatif memengaruhi ketahanan hidup(nilai OR 14,67). Begitu juga dengan komorbiditas memengaruhi ketahanan hidupsebesar 10,54 kali. Lama persiapan operasi tidak bermakna terhadap ketahanan hidup,sedangkan durasi operasi memengaruhi ketahanan hidup sebesar 7,5 kali. Antibiotikaempiris yang sesuai dengan hasil kultur memengaruhi ketahanan hidup sebesar 12,57kali. Kesimpulan: Pemberian antibiotika empiris yang tepat terbukti berhubungandengan ketahanan hidup pasien perforasi tukak peptik.;

---

ABSTRACT

Background: Mortality of patients with peptic ulcer perforation (PUP) was stable at

20-50%, which is the most common cause is sepsis. This challenge prompted the

surgeon to examine the factors associated with mortality and morbidity of this

disease. In addition to surgery to control infection, preoperative antibiotics are

known to reduce mortality. This study aims to determine the suitability of empiric

antibiotics relationship with antibiotic sensitivity culture results to the 30 days

survival of perforated peptic ulcer patients in Dr Cipto Mangunkusumo General

Hospital (RSCM) in Jakarta. Methods: A cohort study of patients PUP since January

2012 to August 2015 at Department of Surgery Faculty of medicine/RSCM Jakarta,

where PUP due to malignancy and penetrating trauma were excluded. Patterns of

bacteria and antibiotics in PUP patients presented as a preliminary study. Results:

45 patients were obtained, the mortality rate of patients in RSCM PUP by 31.1% and

amounted to 68.9% survival. Patterns of bacteria in a patient PUP is Escherichia

coli as most Gram-negative bacteria (35.85%) and Streptococcus alfahemolytic as

most Gram-positive bacteria (15.09%). The second line antibiotics are appropriate

for the PUP patients is sulbactam/ampicillin. There was no relationship between

Boey?s score and survivability, but the preoperative shock affect survival (OR 14.67).

Likewise with comorbidities affecting the survival of 10.54 times. Time to surgery on

survival was not significant, while the duration of surgery affecting the survival of 7.5

times. Empiric antibiotics in accordance with the culture results affects survival of

12.57 times. Conclusion: The provision of appropriate empiric antibiotic shown to be

associated with survival in patients with peptic ulcer perforation. ;Background: Mortality of patients with peptic ulcer perforation (PUP) was stable at20-50%, which is the most common cause is sepsis. This challenge prompted thesurgeon to examine the factors associated with mortality and morbidity of thisdisease. In addition to surgery to control infection, preoperative antibiotics areknown to reduce mortality. This study aims to determine the suitability of empiricantibiotics relationship with antibiotic sensitivity culture results to the 30 dayssurvival of perforated peptic ulcer patients in Dr Cipto Mangunkusumo GeneralHospital (RSCM) in Jakarta. Methods: A cohort study of patients PUP since January2012 to August 2015 at Department of Surgery Faculty of medicine/RSCM Jakarta,where PUP due to malignancy and penetrating trauma were excluded. Patterns ofbacteria and antibiotics in PUP patients presented as a preliminary study. Results:45 patients were obtained, the mortality rate of patients in RSCM PUP by 31.1% andamounted to 68.9% survival. Patterns of bacteria in a patient PUP is Escherichiacoli as most Gram-negative bacteria (35.85%) and Streptococcus alfahemolytic asmost Gram-positive bacteria (15.09%). The second line antibiotics are appropriatefor the PUP patients is sulbactam/ampicillin. There was no relationship betweenBoey?s score and survivability, but the preoperative shock affect survival (OR 14.67).Likewise with comorbidities affecting the survival of 10.54 times. Time to surgery onsurvival was not significant, while the duration of surgery affecting the survival of 7.5times. Empiric antibiotics in accordance with the culture results affects survival of12.57 times. Conclusion: The provision of appropriate empiric antibiotic shown to beassociated with survival in patients with peptic ulcer perforation.;Background: Mortality of patients with peptic ulcer perforation (PUP) was stable at20-50%, which is the most common cause is sepsis. This challenge prompted thesurgeon to examine the factors associated with mortality and morbidity of thisdisease. In addition to surgery to control infection, preoperative antibiotics areknown to reduce mortality. This study aims to determine the suitability of empiricantibiotics relationship with antibiotic sensitivity culture results to the 30 dayssurvival of perforated peptic ulcer patients in Dr Cipto Mangunkusumo GeneralHospital (RSCM) in Jakarta. Methods: A cohort study of patients PUP since January2012 to August 2015 at Department of Surgery Faculty of medicine/RSCM Jakarta,where PUP due to malignancy and penetrating trauma were excluded. Patterns ofbacteria and antibiotics in PUP patients presented as a preliminary study. Results:45 patients were obtained, the mortality rate of patients in RSCM PUP by 31.1% andamounted to 68.9% survival. Patterns of bacteria in a patient PUP is Escherichiacoli as most Gram-negative bacteria (35.85%) and Streptococcus alfahemolytic asmost Gram-positive bacteria (15.09%). The second line antibiotics are appropriatefor the PUP patients is sulbactam/ampicillin. There was no relationship betweenBoey?s score and survivability, but the preoperative shock affect survival (OR 14.67).Likewise with comorbidities affecting the survival of 10.54 times. Time to surgery onsurvival was not significant, while the duration of surgery affecting the survival of 7.5times. Empiric antibiotics in accordance with the culture results affects survival of12.57 times. Conclusion: The provision of appropriate empiric antibiotic shown to beassociated with survival in patients with peptic ulcer perforation."

"ABSTRAKLatar belakang: Sepsis merupakan masalah kesehatan penting yang dapat menyebabkan insidens kematian sampai 50% pada pasien dengan sepsis berat. Antibiotik aminoglikosidaterutama amikasin semakin banyak digunakan untuk mengobati infeksi kuman Gram negatif pada pasien sepsis di ICU, meskipun penggunaan obat tersebut pada dosisterapi dapat meningkatkan risiko kerusakan ginjal sekitar 10-25%. Pemantauan kadar lembah amikasin serta biomarker dini diperlukan untuk mencegah kerusakan ginjal pada pasien sepsis yang dirawat di ICU. Penelitian ini dilakukan untuk mengetahui hubungan kadar lembah amikasin pada pasien ICU dewasa yang dirawat di Rumah Sakit Cipto Mangunkusumo yang diberikan amikasin 1000 mg/hari denganpeningkatan kadar KIM-1 normalisasi dalam urin yang merupakan biomarker dini nefrotoksisitas.Metode:Penelitian ini merupakan penelitian pendahuluan yang dilakukan pada 12 pasien sepsis dewasa yang dirawat di ICU RSCM dan diberikan amikasin 1000 mg/hari pada bulan Mei-September 2015. Kadar lembah amikasin dosis ketiga dihubungkan dengan peningkatan kadar KIM-1 normalisasi yang diukur melalui urin 24 jam setelah pemberian amikasin dosis pertama/kedua dan dosis ketiga.Hasil:Dari 12 subyek penelitian, didapatkan 3 subyek penelitian dengan kadar lembah amikasin di atas 10 g/mL, sedangkan 9 subyek penelitian kadar lembahnya ada dalam batas aman (di bawah 10 g/mL). Delapan dari 12 subyek penelitian (66,7%) mengalami peningkatan kadar KIM-1 normalisasi dalam urin hari ketiga dibandingkan hari pertama. Tidak ada hubungan antara kadar lembah amikasin dengan peningkatan kadar KIM-1 normalisasi dalam urin (p=0,16; r=0,43).Kesimpulan:Pasien sepsis yang mendapat amikasin 1000 mg/hari di ICU RSCM selama 3 hari memperlihatkan kadar lembah amikasin plasma dalam batas aman untuk ginjal.

---

ABSTRACT

Background: Sepsis is a common caused of mortality which may account for up to 50% death rate in patients with severe sepsis. Aminoglycoside antibiotics, especially amikacin, are the most commonly used antibiotics in the septic patients with Gram-negative bacterial infections, despite these drugs may induce nephrotoxicity in 10-25%

patients. Hence, it is essential to monitor amikacin trough plasma concentration and to detect nephrotoxicity as early as possible. The aim of this study is to find out the correlation between amikacin trough plasma concentration with normalized KIM-1 concentration in the urine as a sensitive and specific biomarker.

Methods:

This is a pilot study conducted in 12 septic patients treated with amikacin 1000 mg/day from May, 2015 to September, 2015. The correlation between amikacin

trough plasma concentrations measured at the third doses with the elevation of urine normalized KIM-1 concentrations measured at the first/second and the third doses were evaluated.

Results:

We observed 3 patients with amikacin trough plasma concentration above the safe level (>10 g/mL), while 9 patients had amikacin concentrations within the safe

plasma level (<10 g/mL). Furthermore, we observed 8 out of 12 patients with higher normalized KIM-1 concentrations measured at third doses compared to normalized KIM-1 concentrations measured at first/second doses. There was no correlation between amikacin trough concentration with elevated urine normalized KIM-1

concentration (p=0,16; r=0,43).

Conclusion:

Septic patients treated with amikacin 1000 mg/day hospitalized in ICU RSCM for 3 days have amikacin safe trough plasma concentration."

"Latar Belakang: COVID-19 telah ditetapkan WHO sebagai Kedaruratan Kesehatan Masyarakat Yang Meresahkan Dunia dengan case fatality rate (CFR) di Indonesia mencapai 8,7% pada April 2020. Sampai saat ini belum ada biomarker prognosis untuk membedakan pasien yang membutuhkan perhatian segera dan menjadi prediktor mortalitas COVID-19 di ICU. Skor Simplified Acute Physiology Score 3 (SAPS 3) menilai kondisi pasien sejak pertama kali datang ke rumah sakit dan mengevaluasi data yang diperoleh saat masuk ICU dalam menentukan prediktor mortalitas 28 hari. Tujuan: Studi ini menganalisis hubungan skor SAPS 3 dengan mortalitas 28 hari pada pasien COVID-19 yang dirawat di ICU RSCM dan RSUI. Metode: Penelitian ini merupakan studi kohort retrospektif di Rumah Sakit Cipto Mangunkusumo selama bulan Maret-Agustus 2020. Sebanyak 208 subjek yang sesuai kriteria inklusi dianalisis dari data rekam medis. Data demografis dan penilaian skor SAPS 3 dicatat sesuai data rekam medis. Variabel SAPS 3 yang berpengaruh terhadap mortalitas 28 hari dilakukan analisis bivariat dan regresi logistik multivariat. Kesahihan dinilai menggunakan uji diskriminasi dengan melihat Area Under Curve (AUC) dan uji kalibrasi Hosmer Lemeshow. Titik potong optimal ditentukan secara statistik. Hasil: Angka mortalitas 28 hari akibat COVID-19 periode Maret-Agustus sebesar 43.8%. Variabel SAPS 3 yang secara statistik berpengaruh signifikan (p<0.05) terhadap mortalitas 28 hari pasien COVID-19 di ICU adalah usia, riwayat penggunaan obat vasoaktif sebelum masuk ICU, penyebab masuk ICU (defisit neurologis fokal dan gagal napas), kadar kreatinin dan trombosit. Skor SAPS 3 menunjukkan nilai diskriminasi yang baik (AUC 80.5% Interval Kepercayaan 95% 0.747-0.862) dan kalibrasi yang baik (Hosmer-Lemeshow p=0.395). Titik potong optimal skor SAPS 3 adalah 39 dengan sensitivitas 70.3% dan spesifisitas 74.4%. Kesimpulan: Skor SAPS 3 memiliki hubungan dengan mortalitas 28 hari pada pasien COVID-19 yang dirawat di ICU.

---

Background: COVID-19 has been declared as a Public Health Emergency of International Concern by WHO with case fatality rate (CFR) of 8,7% in April 2020 in Indonesia. Until now, there is no prognostic biomarker to differentiate patients who require immediate attention and be a mortality predictor for COVID-19 patients in ICU. Simplified Acute Physiology Score 3 (SAPS 3) score assessed the patient’s condition since the first time he came to the hospital and evaluated the data obtained in the first hour of admission to the ICU in predicting 28-days mortality. Goals: This study aims to analyze the correlation between SAPS 3 score and 28-days mortality caused by COVID-19 in the ICU RSCM and RSUI.

Methods: This retrospective cohort study was conducted in Cipto Mangunkusumo Hospital from March to August 2020 on 208 subjects who met the inclusion criteria. Demographic data and SAPS 3 score were recorded, the data was taken from medical records. Bivariate and multivariate logistic regression was used to investigate the relationship between SAPS 3 variables and 28-days mortality. The validity of SAPS 3 score was assessed by measurement of the Area Under Curve (AUC) and Hosmer- Lemeshow calibration test. The optimal cut-off point was determined statistically.

Results: The mortality rate of COVID-19 in our study from March to August 2020 is 43.8%. Five SAPS 3 variables were found to be significantly associated with 28-days mortality of COVID-19 patients in the ICU (p<0.05) are age, use of vasoactive drugs before ICU admission, reason for ICU admission (focal neurologic defisit and respiratory failure), creatinine, and thrombocyte level. SAPS 3 showed a good discrimination ability (AUC 80.5% Confidence Interval 95% 0.747-0.862) and calibration ability (Hosmer-Lemeshow p=0.395). The optimal cut off point of SAPS 3 score was 39 with sensitivity 70.3% and specificity 74.4%.

Conclusion: SAPS 3 score have a correlation with 28-days mortality caused by COVID-19 in the ICU."

"Latar Belakang: Sepsis berat dan syok sepsis merupakan penyebab mortalitas dan morbiditas di ruang perawatan intensif. Komplikasi sepsis sangat erat kaitannya dengan penurunan fungsi sistem kardiovaskular yang berisiko berkembang terjadi syok. Deteksi dan resusitasi dini syok pada sepsis bermanfaat mencegah terjadinya hipoperfusi. Berdasarkan protokol EGDT dengan menggunakan parameter mikrosirkulasi sistemik misalnya kadar laktat, ScvO2 dan nilai P(cv-a)CO2 dapat menurunkan angka mortalitas dibanding dengan metode sederhana. Pasien dengan perfusi sistemik yang normal, masih memungkinkan terjadi hipoperfusi regional. Regio splanknik, merupakan salah satu organ yang paling awal mengalami hipoperfusi yang tidak terdeteksi berdasarkan parameter hemodinamik sistemik. Penelitian ini bertujuan untuk menilai hipoperfusi splanknik dengan metode sederhana yaitu volume residu lambung dengan melihat hubungan dengan parameter mikrosirkulasi sistemik yaitu kadar laktat, ScvO2 dan nilai P(cv-a)CO2. Metode: Penelitian ini merupakan studi potong lintang dengan uji korelasi antara volume residu lambung dan kadar laktat, ScvO2 dan nilai P(cv-a)CO2 yang diambil secara konsekutif pada pasien sepsis berat dan syok sepsis pascaresusitasi di ICU RSCM pada bulan Februari 2014 sampai April 2014. Seluruh subyek penelitian dilakukan pengkuran volume residu lambung dan kadar laktat, ScvO2 dan nilai P(cva) CO2 pada jam ke-0, ke-8 dan ke-24. Angka kematian dilihat selama 28 hari kemudian. Hasil: Sebanyak 53 subyek diikutsertakan dalam penelitian ini. Tidak terdapat korelasi secara signifikan antara volume residu lambung dan kadar laktat, ScvO2 dan nilai P(cv-a)CO2 pada jam ke-0, ke-8 dan ke-24. Didapatkan korelasi lemah antara volume residu lambung dan nilai P(cv-a)CO2 pada jam ke-0 (r:0,37 ; p:0.006). Tingkat mortalitas 28 hari sebesar 58,4%, sebagian besar pasien meninggal di ICU. Kesimpulan: Tidak terdapat korelasi secara signifikan antara volume residu lambung dengan kadar laktat, ScvO2 dan nilai P(cv-a)CO2 pada jam ke-0, ke-8 dan ke-24.

---

Background: Severe sepsis and septic shock caused of mortality and morbidity in intensive care. Complications of sepsis is closely associated with a decreasing of cardiovascular system function that can develops to shock. Detection and early resuscitation in septic shock are useful to prevent the hypoperfusion. Based EGDT protocol using systemic microcirculation parameters, for example the levels of lactate, ScvO2 and P (cv-a) CO2 may reduce mortality compared with a simple parameters. Patients with normal systemic perfusion, still allowing regional hypoperfusion. Splanchnic region, is one of the earliest organ hypoperfusion were not detected by the systemic hemodynamic parameters. This study aims to assess splanchnic hypoperfusion with a simple method that gastric residual volume by looking the relationship with systemic microcirculation parameters,that the levels of lactate, ScvO2 and the value of P (cv-a) CO2.

Methods: This study was a cross-sectional study to test the correlation between gastric residual volume and levels of lactate, ScvO2 and the value of P (cv-a) CO2 taken consecutively in patients with postresusitation of severe sepsis and septic shock in ICU RSCM in February 2014 to April 2014. the whole subject of the research carried out taking the measurements of gastric residual volumes and levels of lactate, ScvO2 and the value of P (cv-a) CO2 at 0, 8 and 24. The mortality rate seen during 28 days later.

Results: A total of 53 subjects enrolled in this study. There was no significant correlation between gastric residual volume and levels of lactate, ScvO2 and the value of P (cv-a) CO2 at 0, 8 and 24 hour. Obtained a weak correlation between gastric residual volume and value of P (cv-a) CO2 at-0 (r: 0.37, p: 0.006). The mortality rate was 58.4% 28 days, most of the patients died in the ICU.

Conclusions: There was no significant correlation between the rate of gastric residual volume lactate, ScvO2 and the P (cv-a) CO2 at the 0, 8 th and 24 th."

"Latar Belakang: Hingga saat ini masih terjadi kerancuan penegakkan diagnosis sepsis pada praktik klinik sehari-hari. Belum diketahui performa seluruh kriteria diagnosis sepsis yang telah ada dan performa modifikasi kriteria diagnosis sepsis berdasarkan kenaikan sistem skor modified Sequential Organ Failure Assessment (MSOFA) sebagai pengganti sistem skor SOFA yang membutuhkan pemeriksaan laboratorium lengkap dalam memprediksi luaran pasien infeksi khususnya di negara berkembang termasuk Indonesia. Belum diketahui pula peran penambahan laktat vena pada performa kriteria diagnosis sepsis. Penelitian ini bertujuan menilai performa dan mengembangkan kriteria diagnosis sepsis dalam memprediksi luaran pasien infeksi dewasa di RS Cipto Mangunkusumo (RSCM). Metode: Penelitian kohort retrospektif dilakukan dengan menggunakan data rekam medik dan registri pasien infeksi Divisi Penyakit Tropik dan Infeksi Departemen Ilmu Penyakit Dalam RSCM pasien berusia lebih dari atau sama dengan 18 tahun yang mendapat perawatan di Unit Gawat Darurat (UGD) RSCM selama tahun 2017. Data yang dikumpulkan meliputi catatan karakteristik sampel, data pemeriksaan klinis dan laboratorium variabel bebas, luaran yang terjadi berupa mortalitas dalam perawatan rumah sakit selama 28 hari pengamatan. Hasil Subyek penelitian terdiri atas 1213 pasien. Sebagian besar (52,5%) merupakan pasien laki-laki, dengan median (rentang interkuartil) usia 51 tahun (38;60). Mortalitas terjadi pada 421 (34,7%) pasien. Performa kriteria diagnosis sepsis terbaik untuk memprediksi mortalitas dalam perawatan ditunjukkan oleh sepsis-3 (area under receiver operating characteristic curve [AUROC] 0,75; interval kepercayaan [IK]95% 0,72-0,78), sementara performa terburuk ditunjukkan oleh kriteria systemic inflammatory response syndrome (SIRS) (AUROC 0,56; IK95% 0,52-0,60). Performa kriteria kadar laktat vena baik (AUROC 0,76; IK95% 0,73-0,79) dalam memprediksi mortalitas dalam perawatan pasien infeksi dewasa di RSCM. Penambahan kriteria kadar laktat vena dapat meningkatkan performa kriteria diagnosis sepsis-3 (AUROC 0,80; IK95% 0,77-0,82) secara bermakna dalam memprediksi mortalitas dalam perawatan pasien infeksi dewasa di RSCM (p <0,0001). Simpulan: Performa kriteria diagnosis sepsis terbaik dalam memprediksi mortalitas dalam perawatan pasien infeksi dewasa di RSCM ditunjukkan oleh kriteria sepsis-3. Performa kriteria kadar laktat vena baik dalam memprediksi mortalitas dalam perawatan pasien infeksi dewasa di RSCM. Penambahan kriteria kadar laktat vena dapat meningkatkan performa kriteria diagnosis sepsis-3 dalam memprediksi mortalitas dalam perawatan pasien infeksi dewasa di RSCM.

---

Introduction: There is uncertainty on the use of sepsis diagnostic criteria in daily clinical practice. The performance of all established sepsis diagnosis criteria and modified criteria using increase modified Sequential Organ Failure Assessment (MSOFA) score as a substitute for SOFA score system which need a complete laboratory test in prediciting in-hospital mortality in developing country, including Indonesia, is unknown. The added value of venous lactate concentration on sepsis diagnostic criteria is unknown as well. This study aim to assess the performance and improve sepsis diagnostic criteria in predicting infected adult patients mortality in Cipto Mangunkusumo Hospital. Methods: The retrospective cohort using medical record and infected adult patients (aged 18 years and older) registry of Division of Tropical and Infectious Diseases Internal Medicine Departement Cipto Mangunkusumo Hospital who were hospitalized in Emergency Room on 2017 was done. Sample's characteristics, clinical and laboratory data of independent variables, outcome i.e. 28 days in-hospital mortality were collected.Results: Subjects consist of 1213 patients, predominantly male (52.5%), with median (interquartile range) age of 51 (38;60) years old. Mortality developed in 421 (34.7%) patients. The best performance of sepsis diagnostic criteria in predicting mortality was shown by sepsis-3 criteria (area under receiver operating characteristic curve [AUROC] 0.75; 95% confidence interval [CI] 0.72-0.78). The worst performance of sepsis diagnostic criteria in predicting mortality was shown by systemic inflammatory response syndrome (SIRS) criteria (AUROC 0.56; 95CI% 0.52-0.60). Performance of lactate in predicting mortality was good (AUROC 0.76; 95CI% 0,73-0,79). The addition of lactate criteria significantly improved sepsis-3 criteria performance (AUROC 0.80; 95CI% 0.77-0.82, p <0,0001). Conclusions: The best performance of sepsis diagnostic criteria in predicting infected adult patients mortality in Cipto Mangunkusumo Hospital is shown by sepsis-3 criteria. Performance of lactate in predicting mortality is good. The addition of lactate criteria significantly improved sepsis-3 criteria performance."

"Latar belakang : Definisi sepsis tahun 2016 adalah disfungsi organ yang mengancam kehidupan akibat disregulasi imun terhadap infeksi. Skor PELOD 2 digunakan untuk mengetahui disfungsi organ pada anak dengan sakit kritis.Tujuan : Mengetahui validitas skor PELOD 2 pada disfungsi organ yang mengancam kehidupan pada sepsis dan titik potong optimal skor PELOD 2 terhadap luaran terutama mortalitas.Metode : Penelitian dilaksanakan dari Januari sampai April 2017 di ruang intensif RSUPN Cipto Mangukusumo. Pengambilan subjek dengan consecutive sampling dan penilaian skor PELOD 2 dilakukan pada 24 jam pertama. Subjek dipantau untuk mengetahui luaran.Hasil : Diperoleh 52 subjek yang memenuhi kriteria. Nilai diskriminasi skor PELOD 2 adalah 0,85 IK 95 0,745-0,965, kalibrasi dengan Hosmer and Lemeshow test 69,2 p.

---

Background . In 2016, a new definition of sepsis has been created that is a presence of life threatening organ dysfunction cause by a dysregulated host response to infection. PELOD 2 score is stated can be used to discover organ dysfunction in critical ill child.

Objective To discover validity PELOD 2 score to know life threatening organ dysfunction and cut off point of toward outcome of sepsis pediatric patient.

Methods This cross sectional study was conducted from January to April 2017 in Intensive Care Unit ICU of RSUPN Cipto Mangunkusumo. The selection of subject through consecutive sampling and evaluation of PELOD 2 score were performed in the first 24 hours. Subjects were monitored to know the outcome.

Results There were 52 subjects that fulfilled the criteria. Discrimination value of PELOD 2 score was 0.85 95 CI 0.745 0.965 and calibration which was tested by using Hosmer and Lemeshow test 69.2 p."